Skip to main content
Equibles

POM · POMDOCTOR Ltd

Track POM — free

Use POM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research POM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.53 0.00 (-0.40%)
Rebalance outlook locked
Market Cap
$4.92M
Shares
9.27M
Volume · Oct 20 7573 Avg daily vol (3M) 68.47K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.53 Open$0.59 Day$0.45–0.75 52W close$0.53–109.62 Avg vol 30d40K Short int26K · 0.3% float · 1.1d Short vol23% Last earningsJun 30, 2025 DataOct 2025–Oct 2026

Up next

Q2 2025 earnings call transcript
Date not confirmed

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.3%
Latest settlement · 1.1 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Bearish Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 18.4 · elevated Equity put/call 0.55
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −83%
below
Price vs 50-day avg −38%
below
RSI (14) 36
neutral
MACD trend Negative
52-week position 0%
near low
Momentum
relative strength
Very Weak
1-month return −34%
trailing
6-month return −93%
trailing
YTD return −90%
this year
Relative strength −101%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $1 › 200d $3 — 200d above 50d
Institutional flow Distributing
-40% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.28% of float · ▲ +42.1% MoM · 1.1 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
6 holders — 13F breadth
Squeeze score 42
elevated · 0–100
Fundamentals
Weak
Gross margin 13%
EPS growth +3%
Y/Y
Free cash flow $-21.4M
Balance sheet $17.9M
net debt
Quant / Vol
risk profile
Very High
Volatility 224%
annualized · 1-yr
Max drawdown −100%
past year
ATR 29.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 2 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−83% Bearish
Price vs 50-day avg
−38% Bearish
RSI (14)
36 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $3 — 200d above 50d
Institutional flow Distributing
-40% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.28% of float · ▲ +42.1% MoM · 1.1 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
6 holders — 13F breadth
Price context
position in its 52-week range
Range low $1 Now $1 · 0% Range high $110
vs 200-day avg -83% vs 50-day avg -38%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Pharmaceutical Retailers — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
POM
POMDOCTOR Ltd
this stock
$4.92M — — — 0.3%
RTEZ
REST EZ Inc.
 $4.20B — -100.0% — 0.0%
HITI
High Tide Inc.
 $233.55M -1.1% — — 0.8%
BHIC
BioScience Health Innovations, Inc.
 $79.68M — +208.3% — 0.0%
SHFH
Scientist Home Future Health Ltd
 $40.32M — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
6
% held
0.3%
Net QoQ
-20.4K sh
Top holder
CITADEL ADVISORS LLC
Held Float
View
Held by Funds
Fund positions
1
View
Short & Settlement
Short Interest Rising
Shares short
26.0K
Days to cover
1.1d
Change
+7.7K sh
View
Short Volume
Short vol %
23%
As of
Oct 19, 2026
Short Total
View
Fails to Deliver
FTD shares
215
Value
$215
As of
Sep 25, 2026
View
Off-Exchange
Off-exchange %
54.5%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
CNY 399.9M
EPS diluted
CNY -395.28
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 19, 2026
This year
25

POMDOCTOR LIMITED has commenced termination of its American Depositary Receipt program and will list its Class A ordinary shares directly on Nasdaq under the symbol "POM" when the market opens on October 21, 2026, alongside a 10-to-1 share consolidation.

View
Earnings & Events
Webcasts
Last webcast
Jun 30, 2025
View

Performance

5D 20D 120D MTD YTD
POM -14.4% -33.6% -93.0% -43.2% -90.0%
SPY -1.5% -0.9% +7.7% +0.5% +12.4%
vs SPY -12.9% -32.7% -100.7% -43.7% -102.4%
Key facts CIK 1877971 CUSIP 73181R207 Visit website Investor relations